COMPANY

EndoSound

Location: Portland, OR · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $250K (Form D filed Jun 17, 2026). SEC Form D 0001850978-26-000009 (Jun 17, 2026)
Evidence (1 event)
- Jun 17, 2026 · SEC Form D 0001850978-26-000009
  Name of Issuer: EndoSound, Inc.; CIK: 1850978; Address: Portland, OR; Submission type: D; Filing date: 2026-06-17; Industry Group: Other Health Care; Date of First Sale: 2026-06-05; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 5000000; Total Amount Sold: 250000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Oct 17, 2025 FDA FDA 510(k) clearance: Biopsy Port Adapter — K250145, Oct 17, 2025. Applicant at approval: Endosound, Inc. source ↗

Oct 17, 2025 FDA 510(k) clearance: Biopsy Port Adapter — K250145, Oct 17, 2025. Applicant at approval: Endosound, Inc. source ↗

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12